Skip to main content
Year archive

Kuros Biosciences Ltd. — 2010 filings

All 21 regulatory filings released by Kuros Biosciences Ltd. (KURN) in 2010, sourced directly from the official regulator.

21 Filings
2010 Period
2010 filings (21)
Filing Released Lang
A*STAR and Cytos extend Influenza Vaccine Collaboration to Supply of Clinical Trial Material
Regulatory Filings
2010-12-16 English
Cytos Biotechnology, A*STAR and INRS present new flu vaccine data at the World Influenza Congress
Regulatory Filings
2010-12-09 English
New clinical study started with the nicotine vaccine NIC002
Regulatory Filings
2010-11-05 English
Cytos Biotechnology Third Quarter Report 2010
Report Publication Announcement 9M 2010
2010-10-28 English
National Institutes of Health, SAIC, and Cytos Biotechnology Collaborate on Malaria Vaccines Research
Earnings Release FY 2010
2010-10-21 English
Dr. Hans Stocker (61) will resign as EVP Regulatory Affairs of Cytos Biotechnology Ltd at the end of 2010
Board/Management Information
2010-09-28 English
Cytos Biotechnology establishes strong patent position around core technology for CYT003-QbG10 in the treatment of allergic asthma and rhinitis
Regulatory Filings
2010-09-28 English
Cytos Biotechnology Presents Novel Toll-Like Receptor 9 Agonist CYT003-QbG10 for the Treatment of Allergic Asthma at the 2010 Annual Conference of the European Respiratory Society
Environmental & Social Information
2010-09-21 English
Cytos Biotechnology to Present at the 2010 Annual Conference of the European Respiratory Society in Barcelona, Spain
Environmental & Social Information
2010-09-07 English
Cytos Biotechnology Second Quarter Report 2010
Earnings Release H1 2010
2010-07-22 English
A*STAR and Cytos Biotechnology establish influenza vaccine collaboration
Regulatory Filings
2010-07-15 English
Cytos Biotechnology Ltd and Intercell AG close the sale of the platform technology
M&A Activity
2010-06-08 English
Cytos Biotechnology Ltd: CYT003-QbG10 phase IIb data presented at EAACI 2010 in London, UK
Regulatory Filings
2010-06-04 English
Cytos Biotechnology Ltd: Placebo-controlled phase II study shows CYT003-QbG10 is safe and efficacious for the treatment of allergic asthma
Regulatory Filings
2010-05-21 English
Cytos Biotechnology sells platform technology for the identification of monoclonal antibodies to Intercell
M&A Activity
2010-05-06 English
Harry Welten becomes new CFO at Cytos Biotechnology Ltd
Board/Management Information
2010-04-30 English
Cytos Biotechnology Ltd: Constitution of the Board of Directors after the Shareholders' Meeting 2010
Board/Management Information
2010-04-23 English
Cytos Biotechnology Ltd First Quarter Report 2010
Earnings Release Q1 2010
2010-04-22 English
Jakob Schlapbach (59) will resign as CFO of Cytos Biotechnology Ltd during the year 2010 and will be proposed to become a member of the board of directors
Board/Management Information
2010-03-22 English
Cytos Biotechnology Ltd: Dr. Thomas Hecht succeeds Dr. Francois L'Eplattenier as chairman of the Board of Directors
Board/Management Information
2010-03-04 English
Cytos Biotechnology announces full year 2009 financial results and major developments in 2009
Earnings Release FY 2009
2010-02-03 English